Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: An analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)

European Heart Journal

Volumn 30, Issue 12, 2009, Pages 1450-1456

  Berry, Colin ^a   Pieper, Karen S ^b   White, Harvey D ^c   Solomon, Scott D ^d   Van De Werf, Frans ^e   Velazquez, Eric J ^b   Maggioni, Aldo P ^f   Califf, Robert M ^b   Pfeffer, Marc A ^d   McMurray, John J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Green Lane Cardiovascular Service ^*  (New Zealand)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f ANMCO RESEARCH CENTER   (Italy)

Author keywords

Coronary artery bypass graft; Coronary artery disease; Myocardial infarction; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIGITALIS; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SEROTONIN UPTAKE INHIBITOR; VALSARTAN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEPRESSION; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; THROMBOSIS;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 67651091774     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp102     Document Type: Article

References (30)

1. Ferguson TB Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL; STS National Database Committee. A decade of change - risk profiles and outcomes for isolated artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg 2002; 73:480-489.
2. The Society for Cardiothoracic Surgery in Great Britain and Ireland. Fifth National Adult Cardiac Surgical Database Report 2003. http://www.scts.org/ documents/PDF/5thBlueBook2003.pdf (Accessed 27 January 2009).
3. Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K, Ernst M, Krian A. Cardiac surgery in Germany during 2006: A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2007; 55:343-350.
4. Hobbs MS, McCaul KA, Knuiman MW, Rankin JM, Gilfillan I. Trends in coronary artery revascularization procedures in Western Australia, 1980-2001. Heart 2004; 90:1036-1041.
5. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR; NRMI Investigators. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28:616-626.
6. Cameron AA, Davis KB, Rogers WJ. Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). J Am Coll Cardiol 1995; 26:895-899.
7. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz AD, Frederick PD, Every N. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36:2056-2063.
8. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005; 294:448-454.
9. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van de Werf F, Avezum A, Goodman SG, Flather MD, Fox KA; Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163:2345-2353.
10. Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, Dabbous O, Fox KA, Gore JM. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2004; 93:288-293.
11. Pfeffer MA, McMurray J, Leizorovicz A, Maggioni AP, Rouleau JL, Van de Werf F, Henis M, Neuhart E, Gallo P, Edwards S, Sellers MA, Velazquez E, Califf R. Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J 2000; 140:727-734.
12. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349:1893-1906.
13. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342:821-828.
14. Labinaz M, Sketch MH Jr, Ellis SG, Abramowitz BM, Stebbins AL, Pieper KS, Holmes DR Jr, Califf RM, Topol EJ. Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J 2001; 141:469-477.
15. Labinaz M, Kilaru R, Pieper K, Marso SP, Kitt MM, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2002; 105:322-327.
16. Waters DD, Pelletier GB, Haché M, Théroux P, Campeau L. Myocardial infarction in patients with previous coronary artery bypass surgery. J Am Coll Cardiol 1984; 3: 909-915.
17. Crean PA, Waters DD, Bosch X, Pelletier GB, Roy D, Théroux P. Angiographic findings after myocardial infarction in patients with previous bypass surgery: explanations for smaller infarcts in this group compared with control patients. Circulation 1985; 71:693-698.
18. Stone GW, Brodie BR, Griffin JJ, Grines L, Boura J, O'Neill WW, Grines CL. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators. J Am Coll Cardiol 2000; 35:605-611.
19. Wiseman A, Waters DD, Walling A, Pelletier GB, Roy D, Théroux P. Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. J Am Coll Cardiol 1988; 12:873-880.
20. Moise A, Lespérance J, Théroux P, Taeymans Y, Goulet C, Bourassa MG. Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 non-operated patients. Am J Cardiol 1984; 54:1176-1181.
21. Janardhanan R, Kenchaiah S, Velazquez EJ, Park Y, McMurray JJ, Weaver WD, Finn PV, White HD, Marin-Neto JA, O'Connor C, Pfeffer MA, Califf RM, Solomon SD; VALIANT Investigators. Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. Am Heart J 2006; 152:183-189.
22. Schömig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, Martinoff S, Neumann FJ, Schwaiger M. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 2000; 343:385-391.
23. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated PCI in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006; 367:569-578.
24. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicenter study. FRagmin and Fast Revascularization during InStability in Coronary artery disease Investigators. Lancet 1999; 354:708-715.
25. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ; Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002; 360:743-751.
26. Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TR, Wheatley DJ, Knight R, Pocock SJ. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 2005; 366:914-920.
27. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879-1887.
28. de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt FW; Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005; 353:1095-1104.
29. Shah SJ, Waters DD, Barter P, Kastelein JJP, Shepherd J, Wenger NK, DeMicco DA, Breazna A, LaRosa JC. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol 2008; 51:1938-1943.
30. Reiner JS, Lundergan CF, Kopecky SL, Topp H, Boyle D, Ross AM. Ineffectiveness of thrombolysis for acute MI following vein graft occlusion. Circulation 1996; 94(Suppl I):1-570.